Fusobacterium nucleatum CbpF Mediates Inhibition of T Cell Function Through CEACAM1 Activation.

Saved in:
Bibliographic Details
Title: Fusobacterium nucleatum CbpF Mediates Inhibition of T Cell Function Through CEACAM1 Activation.
Authors: Galaski J; The Concern Foundation Laboratories at the Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research, Institute for Medical Research Israel Canada (IMRIC), Faculty of Medicine, The Hebrew University Medical School, Jerusalem, Israel.; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Shhadeh A; The Institute of Dental Sciences, The Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel., Umaña A; Department of Biochemistry, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States., Yoo CC; Department of Biochemistry, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States., Arpinati L; Institute of Pulmonary Medicine, Hebrew University Hadassah Medical Center, Jerusalem, Israel., Isaacson B; The Concern Foundation Laboratories at the Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research, Institute for Medical Research Israel Canada (IMRIC), Faculty of Medicine, The Hebrew University Medical School, Jerusalem, Israel., Berhani O; The Concern Foundation Laboratories at the Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research, Institute for Medical Research Israel Canada (IMRIC), Faculty of Medicine, The Hebrew University Medical School, Jerusalem, Israel., Singer BB; Institute of Anatomy, Medical Faculty, University Duisburg-Essen, Essen, Germany., Slade DJ; Department of Biochemistry, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States., Bachrach G; The Institute of Dental Sciences, The Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel., Mandelboim O; The Concern Foundation Laboratories at the Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research, Institute for Medical Research Israel Canada (IMRIC), Faculty of Medicine, The Hebrew University Medical School, Jerusalem, Israel.
Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2021 Jul 15; Vol. 11, pp. 692544. Date of Electronic Publication: 2021 Jul 15 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2235-2988
DOI:10.3389/fcimb.2021.692544